cyclosporine has been researched along with Vascular Diseases in 47 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 22 (46.81) | 18.2507 |
2000's | 17 (36.17) | 29.6817 |
2010's | 7 (14.89) | 24.3611 |
2020's | 1 (2.13) | 2.80 |
Authors | Studies |
---|---|
Ahmed, RM; Maamoun, H; Soliman, AR; Soliman, H | 1 |
Brennan, J; Coulston, J; Kennedy, T; Millen, A | 1 |
Andersson, B; Andreassen, AK; Arora, S; Aukrust, P; Bøtker, HE; Dellgren, G; Eiskjaer, H; Erikstad, I; Gude, E; Gullestad, L; Gustafsson, F; Ioanes, D; Rådegran, G; Sigurdardottir, V; Solberg, OG; Solbu, D; Ueland, T | 1 |
Andersson, B; Andreassen, AK; Arora, S; Dellgren, G; Eiskjaer, H; Gude, E; Gullestad, L; Gustafsson, F; Jansson, K; Karason, K; Rådegran, G; Solbu, D | 1 |
Bu, H; Wang, J; Wang, W; Zhang, P | 1 |
Hirsch, GM; Lee, TD; Zaki, AM | 1 |
Gareau, A; Hirsch, GM; Lee, TD; Nashan, B | 1 |
Böhmer, AE; Brum, LM; Hansel, G; Portela, LV; Souza, DG; Souza, DO | 1 |
Agüero, J; Almenar-Bonet, L; Buendía-Fuentes, F; Martínez-Dolz, L; Navarro-Manchón, J; Raso-Raso, R; Salvador-Sanz, A; Sánchez-Lázaro, IJ | 1 |
Gareau, AJ; Hirsch, GM; Lee, TD; Nashan, B | 1 |
Chadban, SJ; Eris, JM; Hambly, BD; Ko, HT; Wu, H; Wyburn, K; Yin, JL | 1 |
Barten, M; Gummert, J; Mohr, FW; Olbrich, HG; Richter, H; Richter, MH; Schramm, D; Weinert, M | 1 |
Bruijn, JA; Claas, FH; de Fijter, JW; Doxiadis, II; Paul, LC; Sijpkens, YW; van Kemenade, FJ; Zwinderman, AH | 1 |
Bruch, D; Da Silva, M; Kittur, DS; Kittur, S; Siddiqui, J; Singh, B; Wilasrusmee, C; Wilasrusmee, S | 1 |
Brazzola, P; Champagne, J; Champagne, MA; Dalle, JH; Duval, M; Fournet, JC; Gauvin, F | 1 |
Brown, L; Coombes, JS; Fassett, RG; Fenning, A; Lexis, LA | 1 |
Bailey, L; Beeson, WL; Chinnock, RE; Fitts, J; Hathout, E; Johnston, J; Kuhn, M; Razzouk, A | 1 |
Schut, NH | 1 |
Ayala, JM; Azimzadeh, AM; DeMartino, JA; Iliff, S; Kawka, DW; Lu, M; Lyons, K; Miller, GG; Mills, SG; Mudgett, JS; Nguyen, BN; Peterson, LB; Pierson, RN; Schröder, C; Siciliano, SJ; Singer, II; Springer, MS; Wu, G; Zhang, T | 1 |
Branzoli, SE; McGregor, CG; Miyagi, N; O'Brien, T; Rao, VP; Ricci, D; Russell, SJ; Tazelaar, HD | 1 |
Bang, D; Bodaghi, B; Chamberlain, AM; Gul, A; Hatemi, G; Houman, MH; Kötter, I; Olivieri, I; Salvarani, C; Sfikakis, PP; Silman, A; Siva, A; Stanford, MR; Stübiger, N; Yazici, H; Yurdakul, S | 1 |
Habuchi, T; Inoue, K; Inoue, T; Kagaya, H; Komatsuda, A; Kumazawa, T; Miura, M; Obara, T; Saito, M; Satoh, S; Tsuchiya, N; Tsuruta, H; Yuasa, T | 1 |
Brugger, S; Greinix, HT; Höcker, P; Kalhs, P; Keil, F; Knöbl, P; Kyrle, PA; Linkesch, W; Schneider, B; Schwarzinger, I | 1 |
Alpers, CE; Andoh, T; Bennett, WM; Burdmann, EA; Couser, WG; Johnson, RJ; Young, BA | 1 |
Azuma, H; Heemann, U; Schmid, C; Tilney, NL | 1 |
Bradstock, KF; Gottlieb, D; Srivastava, A | 1 |
Mihatsch, MJ; Strøm, EH; Thiel, G | 1 |
Becker, GJ; Choy, BY; Walker, RG | 1 |
Charba, D; Harris, MA; Hester, JP; Moake, JL | 1 |
Alexander, JW; Demmy, AM; First, MR; Hariharan, S; Munda, R; Schroeder, TJ | 1 |
de Ridder, L; Lameire, N; Van de Voorde, J; Verbeke, M | 1 |
Cardella, C; Cattran, D; Cole, E; Fenton, S; Katz, A; Quaggin, S; Wade, J; Zaltzman, J; Zent, R | 1 |
Heemann, U; Schmid, C; Tilney, NL | 1 |
Hishida, A; Matsushima, H | 1 |
Andoh, TF; Bennett, WM; Gardner, MP | 1 |
Ding, XQ; Hatori, M; Kokado, Y; Kyakuno, M; Kyo, M; Miki, T; Miyamoto, M; Nakamura, T; Okada, M; Okuyama, A; Takahara, S; Toki, K | 1 |
Ichimaru, N; Imai, E; Kokado, Y; Kyakuno, M; Kyo, M; Nakamura, T; Namba, Y; Oka, K; Okada, M; Okuyama, A; Takahara, S; Toki, K; Yamashiro, H | 1 |
Bosch, T; Buhmann, R; Kolb, HJ; Lennertz, A; Samtleben, W | 1 |
Allan, JS; Aretz, HT; Choo, JK; Erhorn, AE; Madsen, JC; Mawulawde, K; Menard, MT; Sachs, DH; Shimizu, A; Slisz, JK; Yamada, K | 1 |
Goldstein, J; Goyal, M; Mallory, GB; Wong, M; Yamada, KA | 1 |
Ichimaru, N; Imai, E; Kojima, Y; Kokado, Y; Kyakuno, M; Kyo, M; Miyamoto, M; Morozumi, K; Nakamura, T; Oka, K; Okuyama, A; Permpongkosol, S; Takahara, S; Tanaka, T; Toki, K; Wang, JD | 1 |
Baan, CC; Balk, AH; de Groot-Kruseman, HA; Loonen, EH; Maat, AP; Mol, WM; Niesters, HG; Weimar, W | 1 |
Benamenyo, JP; Droz, D; Niaudet, P | 1 |
Hiller, E; Holler, E; Kolb, HJ; Seeber, C | 1 |
Alpers, CE; Collins, BS; Davis, CL; Marsh, CL; McVicar, JP; Perkins, JD | 1 |
Albert, FW; Banfi, G; Gudat, F; Mihatsch, MJ; Morozumi, K; Thiel, G | 1 |
Berkenboom, G; Fang, ZY; Fontaine, J; Goldman, M; Unger, P | 1 |
1 review(s) available for cyclosporine and Vascular Diseases
Article | Year |
---|---|
[Cyclosporine nephrotoxicity (chronic arteriolopathy, glomerulopathy)].
Topics: Chronic Disease; Cyclosporine; Humans; Immunosuppressive Agents; Kidney; Kidney Diseases; Kidney Glomerulus; Vascular Diseases | 1997 |
6 trial(s) available for cyclosporine and Vascular Diseases
Article | Year |
---|---|
Steroid resistant focal segmental glomerulosclerosis: effect of arterial hyalinosis on outcome: single center study.
Topics: Adult; Arterioles; Blood Pressure; Cyclosporine; Diarrhea; Drug Resistance; Drug Therapy, Combination; Eye Diseases, Hereditary; Female; Fibrosis; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucocorticoids; Humans; Hyalin; Immunosuppressive Agents; Intestinal Diseases; Male; Mycophenolic Acid; Prednisolone; Prospective Studies; Proteinuria; Skin Abnormalities; Treatment Outcome; Vascular Diseases | 2021 |
The Effect of Everolimus Initiation and Calcineurin Inhibitor Elimination on Cardiac Allograft Vasculopathy in De Novo Recipients: One-Year Results of a Scandinavian Randomized Trial.
Topics: Adult; Allografts; Calcineurin Inhibitors; Cyclosporine; Drug Therapy, Combination; Everolimus; Female; Follow-Up Studies; Graft Rejection; Graft Survival; Heart Diseases; Heart Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Postoperative Complications; Prognosis; Risk Factors; Sirolimus; Transplant Recipients; Vascular Diseases | 2015 |
Everolimus Initiation With Early Calcineurin Inhibitor Withdrawal in De Novo Heart Transplant Recipients: Three-Year Results From the Randomized SCHEDULE Study.
Topics: Adolescent; Adult; Aged; Allografts; Calcineurin Inhibitors; Cyclosporine; Everolimus; Female; Follow-Up Studies; Glomerular Filtration Rate; Graft Rejection; Graft Survival; Heart Diseases; Heart Transplantation; Humans; Immunosuppressive Agents; Kidney Function Tests; Male; Middle Aged; Postoperative Complications; Prognosis; Prospective Studies; Risk Factors; Transplant Recipients; Vascular Diseases; Withholding Treatment; Young Adult | 2016 |
Preliminary results of a prospective randomized study of cyclosporine versus tacrolimus in the development of cardiac allograft vasculopathy at 1 year after heart transplantation.
Topics: Cyclosporine; Heart Transplantation; Humans; Immunosuppressive Agents; Prospective Studies; Tacrolimus; Vascular Diseases | 2010 |
Conversion from cyclosporine to tacrolimus after pancreas transplantation.
Topics: Adult; Cyclosporine; Female; Graft Rejection; Humans; Kidney; Kidney Transplantation; Male; Middle Aged; Pancreas Transplantation; Reoperation; Safety; Tacrolimus; Vascular Diseases | 1995 |
Morphological findings in non-episode biopsies of kidney transplant allografts treated with FK506 or cyclosporine.
Topics: Biopsy; Cyclosporine; Humans; Immunosuppressive Agents; Kidney; Kidney Diseases; Kidney Transplantation; Postoperative Complications; Tacrolimus; Vascular Diseases | 1998 |
40 other study(ies) available for cyclosporine and Vascular Diseases
Article | Year |
---|---|
The use of immunosuppressive agents in the management of recalcitrant lower limb ulcers.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Chronic Disease; Cyclophosphamide; Cyclosporine; Female; Hospitals, University; Humans; Immunomodulation; Immunosuppressive Agents; Leg Ulcer; Lower Extremity; Male; Middle Aged; Tertiary Care Centers; Treatment Outcome; Vascular Diseases; Wound Healing | 2014 |
Cyclosporine A aggravates vascular endothelial injury in hyperlipidemic rats by down-regulating decay-accelerating factor.
Topics: Animals; CD55 Antigens; Cells, Cultured; Cyclosporine; Endothelium, Vascular; Humans; Hyperlipidemias; Immunosuppressive Agents; Male; Rats; Rats, Wistar; Umbilical Cord; Vascular Diseases; Vascular Endothelial Growth Factor A | 2009 |
Contribution of pre-existing vascular disease to allograft vasculopathy in a murine model.
Topics: Animals; Aorta; Apolipoproteins E; Atherosclerosis; CD4-Positive T-Lymphocytes; Cyclosporine; Disease Models, Animal; Foam Cells; Graft Rejection; Green Fluorescent Proteins; Macrophages; Male; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Tissue Donors; Transplantation, Homologous; Tunica Intima; Tunica Media; Vascular Diseases | 2009 |
Contribution of B cells and antibody to cardiac allograft vasculopathy.
Topics: Actins; Animals; Antibody-Dependent Cell Cytotoxicity; Aorta, Abdominal; B-Lymphocytes; Cyclosporine; Disease Models, Animal; Heart Transplantation; Homeodomain Proteins; Humans; Immunization, Passive; Immunosuppressive Agents; In Vitro Techniques; Isoantibodies; Lymphocyte Depletion; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Knockout; Transplantation, Homologous; Vascular Diseases | 2009 |
Long-term cyclosporine treatment in non-transplanted rats and metabolic risk factors of vascular diseases.
Topics: Animals; Blood Coagulation; Body Weight; Cyclosporine; Fibrinogen; Glucose Tolerance Test; Homocysteine; Humans; Immunosuppressive Agents; Insulin; Leptin; Lipids; Male; Rats; Rats, Wistar; Risk Factors; Vascular Diseases | 2010 |
Cyclosporine immunosuppression does not prevent the production of donor-specific antibody capable of mediating allograft vasculopathy.
Topics: Animals; Antibody Specificity; Calcineurin Inhibitors; Cyclosporine; Graft Rejection; Heart Transplantation; Immunosuppressive Agents; Isoantibodies; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Models, Animal; T-Lymphocytes; Tissue Donors; Transplantation, Homologous; Vascular Diseases | 2012 |
Sirolimus reduces vasculopathy but exacerbates proteinuria in association with inhibition of VEGF and VEGFR in a rat kidney model of chronic allograft dysfunction.
Topics: Animals; Cell Proliferation; Cells, Cultured; Cyclosporine; Disease Models, Animal; Immunosuppressive Agents; In Vitro Techniques; Kidney Transplantation; Male; Podocytes; Proteinuria; Rats; Rats, Inbred F344; Rats, Inbred Lew; Receptors, Vascular Endothelial Growth Factor; Signal Transduction; Sirolimus; Transplantation, Homologous; Vascular Diseases; Vascular Endothelial Growth Factor A | 2013 |
Cyclosporin A does not enhance the development of transplant vasculopathy: experimental study in a rat cardiac transplant model.
Topics: Animals; Coronary Stenosis; Cyclosporine; Graft Rejection; Graft Survival; Heart Transplantation; Immunosuppressive Agents; Postoperative Complications; Rats; Rats, Inbred F344; Rats, Inbred Lew; Vascular Diseases | 2002 |
Chronic rejection with or without transplant vasculopathy.
Topics: Acute Disease; Adult; Atrophy; Chronic Disease; Cohort Studies; Cyclosporine; Fibrosis; Graft Rejection; Graft Survival; Humans; Kidney Transplantation; Kidney Tubules; Logistic Models; Risk Factors; Time Factors; Vascular Diseases | 2003 |
Morphological and biochemical effects of immunosuppressive drugs in a capillary tube assay for endothelial dysfunction.
Topics: Cell Survival; Cyclosporine; Dexamethasone; Endothelin-1; Endothelium, Vascular; Epoprostenol; Humans; Immunosuppressive Agents; In Vitro Techniques; Mycophenolic Acid; Sirolimus; Tacrolimus; Vascular Diseases | 2003 |
Fatal diffuse capillaritis after hematopoietic stem-cell transplantation for dyskeratosis congenita despite low-intensity conditioning regimen.
Topics: Adolescent; Capillaries; Cerebral Hemorrhage; Cyclosporine; Dyskeratosis Congenita; Erythrocyte Transfusion; Esophagus; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Male; Mucous Membrane; Necrosis; Platelet Transfusion; Time Factors; Transplantation Conditioning; Vascular Diseases | 2005 |
Antioxidant supplementation enhances erythrocyte antioxidant status and attenuates cyclosporine-induced vascular dysfunction.
Topics: alpha-Tocopherol; Animals; Antioxidants; Aorta, Thoracic; Creatinine; Cyclosporine; Dietary Supplements; Erythrocytes; Glutathione; Immunosuppressive Agents; Male; Malondialdehyde; Methemoglobin; Rats; Rats, Sprague-Dawley; Superoxides; Thioctic Acid; Vascular Diseases | 2006 |
Cardiac allograft vasculopathy in pediatric heart transplant recipients.
Topics: Adolescent; Angiography; Autopsy; Child; Child, Preschool; Cholesterol; Cyclosporine; Female; Glucose; Graft Survival; Heart Transplantation; Hemodynamics; HLA-DR Antigens; Humans; Immunosuppressive Agents; Infant; Infant, Newborn; Lipids; Lipoproteins, LDL; Logistic Models; Male; Models, Statistical; Multivariate Analysis; Odds Ratio; Proportional Hazards Models; Regression Analysis; Time Factors; Treatment Outcome; Vascular Diseases | 2006 |
Vascular injury mediated by calcineurin inhibitors: contribution of rheological factors?
Topics: Calcineurin Inhibitors; Cyclosporine; Endothelium, Vascular; Erythrocyte Deformability; Hemorheology; Humans; Hypertension; Immunosuppressive Agents; Shear Strength; Vascular Diseases; Vascular Resistance | 2006 |
CCR5 blockade modulates inflammation and alloimmunity in primates.
Topics: Animals; Antibody Formation; Autoimmunity; CCR5 Receptor Antagonists; Cyclosporine; Disease Models, Animal; Graft Survival; Heart Transplantation; HIV Infections; Humans; Immunosuppressive Agents; Inflammation; Isoantibodies; Kidney Transplantation; Macaca fascicularis; Macrophages; Male; Pyrazoles; Stress, Physiological; T-Lymphocytes; Transplantation Tolerance; Transplantation, Homologous; Valine; Vascular Diseases | 2007 |
Recombinant adenoviral gene transfer does not affect cardiac allograft vasculopathy.
Topics: Adenoviridae; Animals; Cyclosporine; Gene Transfer Techniques; Genetic Therapy; Genetic Vectors; Graft Rejection; Heart Transplantation; Immunosuppressive Agents; Random Allocation; Rats; Rats, Inbred BN; Rats, Inbred Lew; Time Factors; Vascular Diseases | 2007 |
EULAR recommendations for the management of Behçet disease.
Topics: Anticoagulants; Arthritis; Behcet Syndrome; Cyclosporine; Evidence-Based Medicine; Gastrointestinal Diseases; Humans; International Cooperation; Nervous System Diseases; Skin Diseases; Uveitis; Vascular Diseases | 2008 |
Thrombotic microangiopathy developing in early stage after renal transplantation with a high trough level of tacrolimus.
Topics: Cyclosporine; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Middle Aged; Tacrolimus; Vascular Diseases | 2008 |
Microangiopathy following allogeneic marrow transplantation. Association with cyclosporine and methylprednisolone for graft-versus-host disease prophylaxis.
Topics: Adult; Bone Marrow Transplantation; Cyclosporine; Female; Follow-Up Studies; Graft Survival; Graft vs Host Disease; Hemolysis; Humans; Hypertension; Immunosuppressive Agents; L-Lactate Dehydrogenase; Male; Methotrexate; Methylprednisolone; Middle Aged; Nervous System Diseases; Plasmapheresis; Platelet Count; Retrospective Studies; Syndrome; Transplantation, Homologous; Vascular Diseases | 1995 |
Cyclosporine A induced arteriolopathy in a rat model of chronic cyclosporine nephropathy.
Topics: Animals; Arterioles; Chronic Disease; Cyclosporine; Diet, Sodium-Restricted; Kidney Diseases; Male; Microscopy, Electron; Rats; Rats, Sprague-Dawley; Vascular Diseases | 1995 |
Rapamycin inhibits transplant vasculopathy in long-surviving rat heart allografts.
Topics: Animals; Cell Division; Cyclosporine; Dose-Response Relationship, Drug; Heart Transplantation; Immunohistochemistry; Immunosuppressive Agents; Male; Polyenes; Rats; Rats, Inbred F344; Rats, Inbred Lew; Sirolimus; Time Factors; Tunica Intima; Vascular Diseases; Ventricular Function | 1995 |
Diffuse alveolar haemorrhage associated with microangiopathy after allogeneic bone marrow transplantation.
Topics: Acute Disease; Adolescent; Adult; Bone Marrow Transplantation; Cyclosporine; Endothelium, Vascular; Fatal Outcome; Female; Hemolytic-Uremic Syndrome; Hemorrhage; Humans; Leukemia, Myeloid; Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative; Lung Diseases; Lymphoma, Non-Hodgkin; Male; Plasma; Plasmapheresis; Platelet Transfusion; Pulmonary Alveoli; Purpura, Thrombotic Thrombocytopenic; Respiratory Insufficiency; Transplantation, Homologous; Vascular Diseases | 1995 |
Prevalence of cyclosporine-associated arteriolopathy in renal transplant biopsies from 1981 to 1992.
Topics: Arterioles; Cyclosporine; Humans; Kidney Transplantation; Prevalence; Retrospective Studies; Time Factors; Transplantation, Homologous; Treatment Failure; Vascular Diseases | 1994 |
Vasculopathy in cyclosporine-treated renal allografts: possible protection by diltiazem.
Topics: Adult; Arterioles; Azathioprine; Cyclosporine; Diltiazem; Female; Humans; Image Processing, Computer-Assisted; Kidney; Kidney Transplantation; Male; Prednisolone; Vascular Diseases | 1994 |
Abnormalities of von Willebrand factor multimers in drug-associated thrombotic microangiopathies.
Topics: Adolescent; Adult; Aged; Antigens; Cyclosporine; Electrophoresis, Agar Gel; Female; Humans; Male; Microcirculation; Polymers; Sodium Dodecyl Sulfate; Thrombosis; Vascular Diseases; von Willebrand Factor | 1993 |
Regional differences in vasculotoxic effects of cyclosporin in rats.
Topics: Acetylcholine; Animals; Aorta; Carotid Arteries; Cyclosporine; Endothelium, Vascular; Immunosuppressive Agents; In Vitro Techniques; Kidney Diseases; Male; Muscle Contraction; Muscle, Smooth, Vascular; Nitroglycerin; Nitroprusside; Rats; Rats, Wistar; Renal Artery; Vascular Diseases; Vasodilator Agents | 1995 |
Thrombotic microangiopathy in renal transplant recipients treated with cyclosporin A.
Topics: Adolescent; Adult; Biopsy; Cyclosporine; Humans; Kidney; Kidney Transplantation; Microcirculation; Middle Aged; Prognosis; Retrospective Studies; Thrombosis; Vascular Diseases | 1997 |
Factors contributing to the development of chronic rejection in heterotopic rat heart transplantation.
Topics: Animals; Chronic Disease; Cyclosporine; Dose-Response Relationship, Drug; Graft Rejection; Heart Transplantation; Histocompatibility Testing; Immunosuppressive Agents; Male; Myocardial Reperfusion Injury; Polyenes; Rats; Rats, Inbred BN; Rats, Inbred F344; Rats, Inbred Lew; Sirolimus; Transplantation, Heterotopic; Vascular Diseases | 1997 |
Protective effects of dietary L-arginine supplementation on chronic cyclosporine nephrotoxicity.
Topics: Animals; Arginine; Blood Pressure; Cyclosporine; Enzyme Inhibitors; Fibrosis; Glomerular Filtration Rate; Immunosuppressive Agents; Kidney; Kidney Diseases; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Sprague-Dawley; Vascular Diseases | 1997 |
[A case of subclinical IgA nephropathy and cyclosporin associated arteriolopathy diagnosed by non-episode biopsy of graft kidney after renal transplantation].
Topics: Biopsy; Cyclosporine; Glomerulonephritis, IGA; Humans; Immunosuppressive Agents; Kidney; Kidney Transplantation; Male; Middle Aged; Renal Artery; Vascular Diseases | 1999 |
Therapeutic plasma exchange in patients suffering from thrombotic microangiopathy after allogeneic bone marrow transplantation.
Topics: Adult; Bone Marrow Transplantation; Cyclosporine; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Pilot Projects; Plasma Exchange; Retrospective Studies; Transplantation, Homologous; Treatment Outcome; Vascular Diseases | 1999 |
The effect of thymectomy on tolerance induction and cardiac allograft vasculopathy in a miniature swine heart/kidney transplantation model.
Topics: Animals; Cyclosporine; Heart Transplantation; Histocompatibility Antigens Class I; Immune Tolerance; Immunosuppressive Agents; Kidney Transplantation; Models, Biological; Swine; Swine, Miniature; Thymectomy; Thymus Gland; Transplantation, Homologous; Vascular Diseases | 1999 |
Neurologic complications of pediatric lung transplantation.
Topics: Adolescent; Adult; Child; Child, Preschool; Cyclosporine; Female; Humans; Hypoxia; Immunosuppressive Agents; Infant; Infant, Newborn; Lung Transplantation; Male; Nervous System Diseases; Prognosis; Pulmonary Circulation; Pulmonary Fibrosis; Retrospective Studies; Risk Factors; Seizures; Stroke; Vascular Diseases | 1999 |
Arteriolopathy in non-episode biopsies of renal transplant allograft.
Topics: Adult; Biopsy; Chi-Square Distribution; Cyclosporine; Female; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Predictive Value of Tests; Statistics, Nonparametric; Tacrolimus; Vascular Diseases | 2000 |
Failure to down-regulate intragraft cytokine mRNA expression shortly after clinical heart transplantation is associated with high incidence of acute rejection.
Topics: Acute Disease; Biopsy; Chemokine CCL2; Cyclosporine; Cytokines; Endocardium; Fibroblast Growth Factor 2; Gene Expression Regulation; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Incidence; Ischemia; Myocardium; RNA, Messenger; Vascular Diseases | 2001 |
One-year routine renal transplant biopsies in children.
Topics: Acute Disease; Adolescent; Adult; Aging; Biopsy; Child; Child, Preschool; Cryopreservation; Cyclosporine; Female; Graft Rejection; Humans; Immunosuppressive Agents; Incidence; Kidney; Kidney Diseases; Kidney Transplantation; Male; Postoperative Period; Renal Circulation; Time Factors; Vascular Diseases | 2001 |
Increased levels of tissue plasminogen activator (t-PA) and tissue plasminogen activator inhibitor (PAI) correlate with tumor necrosis factor alpha (TNF alpha)-release in patients suffering from microangiopathy following allogeneic bone marrow transplanta
Topics: Acute Disease; Adult; beta-Thromboglobulin; Bone Marrow Transplantation; Cyclosporine; Factor VIII; Fibrin Fibrinogen Degradation Products; Graft vs Host Disease; Humans; Microcirculation; Middle Aged; Plasminogen Activator Inhibitor 1; Platelet Factor 4; Prospective Studies; Severity of Illness Index; Tissue Plasminogen Activator; Transplantation, Autologous; Transplantation, Homologous; Tumor Necrosis Factor-alpha; Vascular Diseases; von Willebrand Factor | 1992 |
Reversible cyclosporine arteriolopathy.
Topics: Adult; Arterioles; Biopsy; Cyclosporine; Dose-Response Relationship, Drug; Drug Interactions; Fluconazole; Humans; Kidney Cortex; Kidney Transplantation; Male; Muscle, Smooth, Vascular; Pancreas Transplantation; Vascular Diseases | 1992 |
Studies on morphological outcome of cyclosporine-associated arteriolopathy after discontinuation of cyclosporine in renal allografts.
Topics: Adult; Arterioles; Biopsy; Cyclosporine; Follow-Up Studies; Graft Survival; Humans; Kidney; Kidney Transplantation; Middle Aged; Time Factors; Treatment Outcome; Vascular Diseases | 1992 |
Prevention of cyclosporine A-induced vascular toxicity by pentoxifylline.
Topics: Acetylcholine; Animals; Arginine; Colforsin; Cyclosporine; Endothelium, Vascular; Male; Muscle Contraction; Muscle Relaxation; Muscle, Smooth, Vascular; Neuromuscular Depolarizing Agents; Nitric Oxide; Nitroprusside; omega-N-Methylarginine; Pentoxifylline; Phenylephrine; Rats; Rats, Inbred Strains; Vascular Diseases | 1991 |